Chris Oberbeck
Analyst · Hovde
Thank you, Chris. Slide 4 highlights our key performance metrics for the quarter ended August 31, 2021. When adjusting for the incentive fee accrual related to net capital gains in the second incentive fee calculation and the interest on the redeemed SAF baby bonds during the core period, adjusted NII of $7.0 million was up 11.6% from $6.3 million last quarter and up 27.5% from $5.5 million as compared to last year's Q2. Adjusted NII per share was $0.63, up $0.14 from $0.49 per share last year and up $0.07 from $0.56 per share last quarter. Across the three quarters, weighted average common shares outstanding remained largely unchanged at 11.2 million shares for each quarter. The increase in adjusted NII from last year primarily reflects the higher level of investments and resultant higher interest and other income with AUM up 31% from last year. The increase from Q1 was primarily due to the full period impact of originations made during Q1 as well as the recognition of a $0.6 million interest reserve release to interest income related to our Taco Mac investment that has been removed from non-accrual this quarter. Adjusted NII yield was 8.7%. This yield is up 70 basis points from 8.0% last year and up 110 basis points from 7.6% last quarter. For the second quarter, we experienced a net gain on investments of $3.1 million or $0.28 per weighted average share and a $1.6 million realized loss on extinguishment of our SAF baby bonds and SBIC I debentures or $0.14 per weighted average share, resulting in a total increase in net assets from operations of $7.9 million or $0.71 per share. The $3.1 million net gain on investments was comprised of $1.5 million in net realized gains and $3.4 million in net unrealized appreciation on investments, offset by $0.4 million of income tax expense on realized gains and $1.3 million net deferred tax expense on unrealized appreciation in our [indiscernible] subsidiaries. The $1.5 million net realized gain primarily comprises a $6.4 million realized gain on the sale of the company's Passageways investment, offset by the recognition of a $4.9 million realized loss on the final write-down of the company's My Alarm Center investment. The $3.4 million unrealized appreciation reflects, one, the $6.5 million reversal of previously recognized appreciation and the $4.9 million reversal of previously recognized depreciation on the Passageways realization and the My Alarm Center write-off respectively, and, two, a 1.1% increase in the total value of the remaining portfolio, primarily related to improvements in market spreads, EBITDA multiples and/or revised portfolio company performance. All of the net reduction in the value of the non-CLO portfolio in the first quarter of last year has been more than reversed and the overall portfolio fair value is now 3.8% above cost. Return on equity remains an important performance indicator for us, which includes both realized and unrealized gains. Our return on equity was 14.4% for the last 12 months. Total expenses, excluding interest and debt financing expenses, base management fees and incentive management fees and income taxes, increased from $1.4 million as of the quarter ended August 31, 2020 to $1.8 million this quarter. This represents 1.1% of average total assets, unchanged over these same periods. We have also again added the KPI slides, starting from slide 26 through 29 in the appendix at the end of the presentation, that shows our income statement and balance sheet matrix for the past nine quarters and the upward trends we have maintained. Of particular note is slide 29, highlighting how our net interest margin run rate has almost quadrupled since Saratoga took over management of the BDC, has increased by 8% the past 12 months and has continued to increase in Q2. Moving on to slide 5. NAV was $324.1 million as of this quarter-end, a $3.8 million increase from last quarter and a $25.9 million increase from the same quarter last year, primarily driven by realized and unrealized gains. During Q2, 9,623 shares were repurchased at a cost of $0.2 million at an average price of $25.85 per share, while 5,441 shares were sold for net proceeds of $0.2 million at an average price of $28.86. NAV per share was $28.97 as of quarter-end, up from $28.70 as of last quarter and from 26.68 as of 12 months ago. NAV per share has increased 14 of the past 17 quarters. Our net asset value has steadily increased since 2011. And this growth has been accretive as demonstrated by the increase in NAV per share. We continue to benefit from our history of consistent realized and unrealized gains. On slide 6, you will see a simple reconciliation of the major changes in NII and NAV per share on a sequential quarterly basis. Starting at the top, adjusted NII per share increased from $0.56 per share last quarter to $0.63 per share this quarter, a $0.06 increase in non-CLO net interest income, a $0.01 increase in both CLO interest income and other income; and a $0.01 cent benefit from lower operating expenses were partially offset by a $0.02 decrease due to higher base management fees. Moving on to the lower half of the slide, this reconciles the $0.27 NAV per share increase for the quarter. The $0.57 of GAAP NII and $0.44 of net realized gains and unrealized appreciation on investments were partially offset by $0.16 net expense related to income and deferred taxes on gains, the $0.44 dividend paid in Q2 and a $0.14 realized loss on extinguishment of debt. Slide 7 outlines the dry powder available to us as of quarter-end, which totaled $229.3 million. This was spread between our available cash, undrawn SBA adventures and undrawn secured credit facility. This quarter-end level of available liquidity allows us to grow our assets by an additional 54% without the need for external financing, with $73 million of it being cash and thus fully accretive to NII when deployed and $111 million of it SBA debentures, with an all-in cost of less than 2%, also very accretive. On July 15, 2021, we reopened our existing 4.375% notes due 2026 and issued an additional $125 million of notes at a premium of 1%, resulting in an effective yield of 4.125%, further strengthening our capital structure and reducing our cost of capital significantly. At quarter-end, we used some of those proceeds to redeem our $60 million, 6.25% SAF baby bonds, effectively cutting our interest expense by more than 200 basis points on that amount. SAF has been delisted on NYSE, with our stock again trading at or above NAV per share. We also have an active ATM equity program in place. And finally, just this week, we closed a new three-year, $50 million dollar revolving credit facility with Encina Lender Finance. This facility replaces our existing Madison facility. And with a floating rate of LIBOR plus 4%, with a 75 basis point floor, has reduced our credit facility cost of capital by 100 basis points, while retaining strong structure and flexibility. We remain pleased with our liquidity and leverage position, especially taking into account the overall conservative nature of our balance sheet and the fact that all our debt is long term in nature with no non-SBIC debt maturing within the next four years and mostly fixed rate. Now, we'd like to move on to slides 8 through 11 and quickly review the composition and yield of our investment portfolio. Slide 8 highlights that we now have $666 million of AUM at fair value or $642 million at cost, invested in 43 portfolio companies and one CLO fund. Our first lien percentage is 74% of our total investments, of which 3.5% of that is in first lien, last out positions. On slide 9, you can see how the yield in our core BDC assets, excluding our CLO, as well as our total assets yield has dropped this year. This is partly due to continued tightening of spreads in our market, but also due to a mix shift as some of our higher yielding assets were repaid this quarter. In addition, our equity position this fiscal year has almost doubled from 6.7% to 12.1% in Q2. Some of this equity increase is in the form of preferred equity that earns recurring dividend income that is now reflected in its own dividend income line in the P&L rather than in interest income. And as a reminder, 100 basis points is our lowest floor. So, we do not expect to see further decreases in LIBOR impact interest income. The CLO yield remained steady, almost unchanged at 13.2% quarter-on-quarter. The CLO is currently performing and current. Turning to slide 10. During the second fiscal quarter, we made investments of $116 million in four new portfolio companies and six follow-on investments and had a record $135 million in six repayments plus amortizations, resulting in a net decrease in investments of $19 million for the quarter. On slide 11, you can see the industry breadth and diversity that our portfolio represents. Our investments are spread over 34 distinct industries with a large focus on healthcare, software, IT services and education and healthcare services. In addition to our investment in the CLO, which has included our structured finance securities. Of our total investment portfolio, 12.1% consists of equity interests, which remain a very important part of our overall investment strategy. For the past nine fiscal years, including Q2, we had a combined $63 million of net realized gains from the sale of equity interest or sale or early redemption of other investments. Over two-thirds of these gains were fully accretive to NAV due to the unused capital loss carryforwards that were carried over from when Saratoga took over management of the BDC. Following our Elyria realization last year and My Alarm Center final write-down this quarter, we are again in a cumulative capital loss carryforward tax position, which will offset current and future realized gains. This consistent performance highlights our portfolio credit quality, has helped grow our NAV and is reflected in our healthy, long-term ROE. That concludes my financial and portfolio review. I will now turn the call over to Michael Grisius, our Chief Investment Officer, for an overview of the investment market.